The mutations can be particularly severe in Li-Fraumeni syndrome, in which a mutated TP53 gene dramatically increases the risk of cancers like osteosarcoma, leukemia, breast cancer, brain tumors, and adrenal tumors (Vaddavalli and Schumacher, 2022). This evidence concerns the gene TP53 and leukemia.